Brief: Cesca Therapeutics Announces Q2 Loss Per Share $0.47
Aug 13 (Reuters) - Cesca Therapeutics Inc KOOL.O :
* CESCA THERAPEUTICS ANNOUNCES IMPROVED SECOND QUARTER 2019
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.47
* Q2 REVENUE ROSE 115 PERCENT TO $4.3 MILLION
* AT JUNE 30, 2019, COMPANY HAD CASH AND CASH EQUIVALENTS
TOTALLING APPROXIMATELY $2.4 MILLION
Source text for Eikon: ID:nPnbPwZnva
Further company coverage: KOOL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thermogenesis Holdings
See all newsThermogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Thermogenesis Holdings Says On Jan 8 Co Received Nasdaq Letter Notifying It No Longer Complies With Minimum Bid Price Requirement For Listing On Nasdaq